EJIM High-impact articles

Triglyceride glucose (TyG) index: A promising biomarker for diagnosis and treatment of different diseases by Yuting Sun et al. (2025)

Bridging the gap: Time to integrate sex and gender differences into research and clinical practice for improved health outcomes by Roberta Gualtierotti (2025)

Transforming organ donation and transplantation: Strategies for increasing donor participation and system efficiency by David B. Olawade et al. (2025)

Practical management of severe acute pancreatitis by Karim Hamesch et al. (2025)

Translating evidence into practice: Managing electrolyte imbalances and iron deficiency in heart failure by Ryosuke Sato et al. (2025)

Tularemia for clinicians: An up-to-date review on epidemiology, diagnosis, prevention and treatment by Roberta Maria Antonello et al. (2025)

Chronic obstructive pulmonary disease: A narrative synthesis of its hallmarks for palliative care clinicians by Jacopo D'Andria Ursoleo et al. (2025)

2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension by Kreutz (2024)

Natural history of metabolic dysfunction-associated steatotic liver disease by Lekakis (2024)

Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease by Mellemkjær (2024)

The role of adherence in patients with chronic diseases by Burnier (2024)

Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations? by Portincasa (2024)

Non-invasive testing and risk-stratification in MASLD by Zoncapé (2024)

Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease by Armandi (2024)

Residual cardiovascular risk: when should we treat it? by Gomez-Delgado (2024)

Anticoagulation in atrial fibrillation. A large real-world update by Bo (2024)

From non-adherence to adherence: Can innovative solutions resolve a longstanding problem? by Kardas (2024)

Breakthrough advances enhancing care in ATTR amyloid cardiomyopathy by Porcari (2024)

ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study by Pagura (2024)

Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid by Van Hooff (2024)

Pulmonary hypertension associated to left heart disease: Phenotypes and treatment by Madonna (2024)

Diet and physical exercise in elderly people with obesity: The state of the art by Battista (2024)

Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis by Giosiana Bosco et al. (2025)

Hyperhomocysteinemia is linked to MASLD by Carlo De Matteis et al. (2025)

A large language model-based clinical decision support system for syncope recognition in the emergency department: A framework for clinical workflow integration by Alessandro Giaj Levra et al. (2025)

Risk trajectory of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis by Edoardo Pirera et al. (2025)

Hypertensive heart disease in older patients: considerations for clinical practice by Miguel Camafort et al. (2025)

Safety and efficacy of early initiation of sodium-glucose co-transporter inhibitors 2 in patients hospitalized for acute heart failure: A meta-analysis of randomized controlled trials by Renzo Laborante et al. (2025)

Chronic kidney disease classification according to different formulas and impact on adverse outcomes in patients with atrial fibrillation: A report from a prospective observational European registry by Giuseppe Boriani et al. (2025)

Different impact of chronic kidney disease in older patients with heart failure according to frailty by Pablo Díez-Villanueva et al. (2025)

Modifiable lifestyle factors in the primordial prevention of hypertension in three US cohorts by Rikuta Hamaya et al. (2025)

Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry by Mei (2024)

Role of sex and gender-related variables in development of metabolic syndrome: A prospective cohort study by Alipour (2024)

Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients by Boriani (2024)

Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? by Boriani (2024)

Early prediction of ventilator-associated pneumonia with machine learning models: A systematic review and meta-analysis of prediction model performance by Frondelius (2024)

Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: A systematic review and meta-analysis by Kyriakoulis (2024)

TSLP is localized in and released from human lung macrophages activated by T2-high and T2-low stimuli: relevance in asthma and COPD by Cané (2024)

Prognosis of COVID-19 severity using DERGA, a novel machine learning algorithm by Asteris (2024)

Artificial intelligence in scientific medical writing: Legitimate and deceptive uses and ethical concerns by Ramoni (2024)

The Long-COVID autonomic syndrome in hospitalized patients: A one-year prospective cohort study by Rigo (2024)

Early and accurate diagnosis of steatotic liver by artificial intelligence (AI)-supported ultrasonography by Santoro (2024)

Door-to-antibiotic time and mortality in patients with sepsis: Systematic review and meta-analysis by Leung (2024)

Kidney function and other associated factors of sarcopenia in community-dwelling older adults: The SCOPE study by Moreno-Gonzalez (2024)

Comparative safety and efficacy analysis of GLP-1 receptor agonists and SGLT-2 inhibitors among frail individuals with type 2 diabetes in the era of continuous population ageing by Paschalis Karakasis et al. (2025)

The lowest well tolerated blood pressure: A personalized target for all? by Verdecchia (2024)

Metabolic dysfunction-associated steatotic liver disease: Evolution of the final terminology by Portincasa (2024)

Towards precision medicine in COPD: Targeting type 2 cytokines and alarmins by Varricchi (2024)

Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors combination therapy versus monotherapy and major adverse cardiovascular events: Do the benefits add up? by Karakasis (2024)